Analysis of the medium (M) segment sequence of Guaroa virus and its comparison to other orthobunyaviruses by Briese, Thomas et al.
Short
Communication
Analysis of the medium (M) segment sequence of
Guaroa virus and its comparison to other
orthobunyaviruses




1Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health,
Columbia University, New York, NY 10032, USA
2Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK
Received 20 March 2004
Accepted 21 June 2004
Guaroa virus (GROV), a segmented virus in the genus Orthobunyavirus, has been linked to the
Bunyamwera serogroup (BUN) through cross-reactivity in complement fixation assays of S
segment-encoded nucleocapsid protein determinants, and also to the California serogroup (CAL)
through cross-reactivity in neutralization assays of M segment-encoded glycoprotein determinants.
Phylogenetic analysis of the S-segment sequence supported a closer relationship to the BUN
serogroup for this segment and it was hypothesized that the serological reaction may indicate
genome-segment reassortment. Here, cloning and sequencing of the GROV M segment are
reported. Sequence analysis indicates an organization similar to that of other orthobunyaviruses,
with genes in the order GN–NSm–GC, andmature proteins generated by protease cleavage at one,
and by signalase at possibly three, sites. A potential role of motifs that are more similar to CAL than
to BUN virus sequences with respect to the serological reaction is discussed. No discernable
evidence for reassortment was identified.
Like other orthobunyaviruses, Guaroa virus (GROV) has a
segmented, negative-strand RNA genome that is comprised
of three segments, named small (S), medium (M) and large
(L) (Bouloy et al., 1973; Gentsch & Bishop, 1976; Clewley
et al., 1977; El Said et al., 1979). The S segment of ortho-
bunyaviruses encodes the nucleocapsid protein (N) and a
non-structural protein (NSs) that may modulate viral poly-
merase activity, and acts as an alpha/beta interferon antag-
onist (Gentsch & Bishop, 1978; Bouloy et al., 1984; Elliott,
1985; Bridgen et al., 2001; Weber et al., 2001). The genome-
complementary strand of the M segment includes one open
reading frame (ORF) for a polyprotein that yields the two
surface glycoproteins GN and GC (G2 and G1, respectively;
Lappin et al., 1994) and a non-structural protein (NSm)
of unknown function (Gentsch & Bishop, 1979; Fuller &
Bishop, 1982; Elliott, 1985; Fazakerley et al., 1988; Nakitare
& Elliott, 1993). The L segment directs expression of a large,
virion-associated protein with RNA-dependent RNA poly-
merase activity (Bouloy & Hannoun, 1976; Obijeski et al.,
1976; Elliott, 1989; Endres et al., 1989; Jin & Elliott, 1991).
The International Committee on Taxonomy of Viruses
considers Guaroa virus to be a species distinct from the
species California encephalitis virus (CEV) and Bunyam-
wera virus (BUNV) within the genus Orthobunyavirus of
the family Bunyaviridae (http://www.ncbi.nlm.nih.gov/
ICTVdb/Ictv/index.htm); some investigators have suggested
that GROV should not be included in either the California
serogroup (CAL) or the Bunyamwera serogroup (BUN)
(Whitman & Shope, 1962; Calisher & Maness, 1970;
Wellings et al., 1971; Hunt & Calisher, 1979; Klimas et al.,
1981). Serological assays have shown some link of GROV
to both serogroups. In complement fixation (CF) assays,
serological cross-reactivity was observed with BUN, but
not CAL, members. In contrast, in haemagglutination–
inhibition (HI) and neutralization (NT) assays, cross-
reactivity was evident with CAL, but not BUN, members
(Groot et al., 1959; Casals & Whitman, 1960; Whitman &
Shope, 1962; Tauraso, 1969). Results similar to those of CF
assays were obtained in immunodiffusion, showing no
cross-reactivity between GROV and CAL viruses, but weak
cross-reaction with BUNV and Tensaw virus (Calisher &
Maness, 1970; Wellings et al., 1970). Immunoelectropho-
resis, however, indicated common determinants between
GROV and CAL viruses (Wellings et al., 1971). Reaction in
CF assays is determined by N, whereas reaction in NT/HI
assays is determined by the glycoproteins (Lindsey et al.,
1977; Gentsch et al., 1980; Gonza´lez-Scarano et al., 1982;
Kingsford & Hill, 1983; Ludwig et al., 1991). Discordant
serological reaction may therefore indicate different phylo-
genetic relationships for GROV N (S segment) and the
glycoproteins (M segment). S-segment sequencing sug-
gested a closer relationship to BUN than to CAL viruses;
The GenBank/EMBL/DDBJ accession number for the sequence
reported in this paper is AY380581.
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it has thus been hypothesized that GROV may be a
reassortant virus (Dunn et al., 1994). Here, we report the
GROV M-segment sequence and its analysis in comparison
to other M-segment sequences.
GROV RNA was reverse-transcribed by using Superscript
II (Invitrogen) and amplified by PCR (Saiki et al., 1985)
using primers (1?6 mM; Table 1), dNTPs (200 mM), MgCl2
(Table 1) and BIO-X-ACT polymerase (Bioline) in a PTC-
200 thermocycler (MJ Research) for 45 cycles of 1 min at
92 uC, 1 min at 45–53 uC and 1–2?5 min at 68 uC (Table 1).
Products were cloned and sequenced (Sanger et al., 1977);
analysis using the Wisconsin GCG package (Accelrys)
indicated one ORF of 4254 nt (1418 aa) for the assembled
sequence (GenBank accession no. AY380581).
Downstream of an untranslated region, the antigenomic
strand encodes a protein that is related to GN of other BUN
and CAL viruses (nt 20–943; 35 kDa). The N-terminal sequ-
ence is consistent with a functional signal peptide for mem-
brane translocation (Blobel & Dobberstein, 1975; Lingappa
et al., 1978; von Heijne, 1988), similar to other viruses of the
genus (Fazakerley et al., 1988). In contrast to other ortho-
bunyavirus M-segment sequences, GROV contains three
potential AUG codons, with the first one being in the best
context according to Kozak’s rules (23=A,+4=G; Kozak,
1986, 1991). This potentially results in a N-terminally
extended product (Fig. 1). Cleavage of the signal peptide
at T21 with respect to the first methionine is compatible
with conservation of terminal tripeptides, as suggested
by Lees et al. (1986), although SPV would change to TPV
and RCF to KCF. Prediction of signalase cleavage at T21 or
P23 by SignalP-NN/–HMM (http://www.cbs.dtu.dk/services/;
Nielsen et al., 1997) supports this view (data not shown).
The predicted amino acid sequence for GN contains the
sequence KSLRV/AAR, allowing protease cleavage to sepa-
rate mature GN from the downstreamNSm analogue (xxxx|;
Fig. 1) (Fazakerley et al., 1988). The NSm-like sequence is
characterized by a conserved, N-terminal, hydrophobic
sequence followed by a short deletion, when compared
to other M-segment sequences, and a motif that is con-
served amongst BUN and CAL viruses (G416DFc/t/sNKCg/
rf/qC425). Little conservation was observed around the
NSm/GC junction, so a potential site for cleavage, possibly
executed by signalase (Fazakerley et al., 1988), is not appa-
rent. Cleavage after a conserved alanine residue (A475),
analogous to the termination of NSm in CAL viruses
(Campbell & Huang, 1999), is possible. This would result in
nt 944–1444 encoding NSm (19 kDa). Analysis of the junc-
tion by SignalP predicts three cleavage sites with similar
likelihoods: A472, A475 and A479 (data not shown). Cleavage
after A472 would result in positions 23=V and 21=A,
one of the most frequent combinations in signalase sites.
Cleavage after A479 would imply a long c-region, but would
result in an N-terminal GC-tripeptide E480EP, similar to
BUNV and Cache Valley virus (CVV) [Fig. 1; Germiston
virus (GERV) N-terminus deduced from alignments (Lees
et al., 1986; Gerbaud et al., 1992; Lappin et al., 1994); SignalP
prediction, ATM-LV or VVA-GE]. Cleavage after any of the
three alanines in GROV occurs close to a potential glycosy-
lation site (N492), but even cleavage at A479 would be at the
‘minimum glycosylation distance’ of 13 aa that has been
determined for cleaved internal signals (Nilsson et al., 1994).
The N-terminal portion of the next protein (nt 1445–4273;
108 kDa) is surprisingly divergent from other GC proteins.
The C-terminal moiety, beginning about 150 aa after a
Table 1. Amplification primers




BUN-S5-F 59-GCCGCAGTAGTGTACTACCGATAyA* 0 48 1
M940B-R 59-GCwGCTCTwAGrCTTTTrTAmCCAG 915
M590-F 59-CATGCnTGyTTyAAdCAvCAyATG 580 50 1
M1300-R 59-rbCyrCAyTTrTTdGwGAArTCACC 1265
M940-F 59-TGCCCTGGkTAyAAAAGyCTwAGAGC 936 51 2?5
GRO-D253R 59-CCACAGCTATCAACTGCGCAT 2706
M970-F 59-ATGTGyAArTChArrGGnCCwGC 2450D 52 2
M3270-R 59-CAnCCrAAyTCyTCrCAnCCC 3144
GRO-D149F 59-CTGGCTGCAAAGATGGACG 2640 53 2
GRO-E464R 59-CCTTGCTGTCAATTGTTTTGCA 3908
M3560-F 59-TCnAArGGhTGyGGnAATGT 3465 47 1
M4170-R 59-CCyTCATCyCknACyCkryACATCCA 4061
GRO-U1092 59-GGATGTTGTCGTCCGTAAATGTTATAATAA 3570 45 1d
BUN-S3-R 59-CGCGCCAGTAGTGTGCTACC 4453
*Non-authentic bases added to some primers are indicated by italics.
DPosition of misannealing is given.
dPerformed at 3?5 mM MgCl2 (all other reactions were performed at 3 mM MgCl2).
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conserved potential trypsin cleavage site (tttt, Fig. 1;
Fazakerley et al., 1988), is again conserved when compared
to other M-segment sequences. The 39 non-coding region
shows little conservation and is longer than those of the
other M segments.
Five potential glycosylation sites were identified (+++;
Fig. 1), including an N-terminal site in GC that is conserved
among GC sequences of the CAL viruses and is found in
approximately the same position in GROV (N492); an N-
terminal glycosylation site that is conserved in GC sequences
of sequenced BUN viruses was not found in the majority of
GROV clones analysed. Among 10 clones, six carried AATG-
ACAtA for N616DI (---; Fig. 1), whereas four carried AATG-
ACAcA, encoding the potential glycosylation site N616DT.
Analysis by TopPred2 (http://bioweb.pasteur.fr/seqanal/
interfaces/toppred.html; Claros & von Heijne, 1994) pre-
dicts six major transmembrane regions. Two are predicted
for GN: the signal peptide (aa 6–26) and a second region that
is compatible with a stop-transfer signal/membrane anchor
(aa 210–230), which would result in a cytoplasmic location
for a strictly conserved downstream KTY motif, a stretch of
mostly hydrophobic residues that includes two proline
residues, and the protease cleavage motif. Three transmem-
brane regions are predicted for NSm (aa 315–335, 368–388
and 455–475); the first, located 10 aa downstream of the
GN C-terminus, is compatible with a third internal signal
sequence, with cleavage predicted after G337 by SignalP.
Signalase cleavage close to a cytoplasmic protease site may
resemble the proposed situation at the C/prM cleavage site
of flaviviruses (Stocks & Lobigs, 1998; Amberg & Rice,
1999). One transmembrane region (aa 1372–1392), a poten-
tial membrane anchor (Fazakerley et al., 1988; Pekosz et al.,
1995), is predicted for GC. The overall topology appears to
be well-conserved, as indicated by conservation of the
same cysteine residues as in the polyproteins of all other
BUN and CAL viruses (Fig. 1) (Lees et al., 1986; Grady et al.,
1987; Pardigon et al., 1988). Conservation of sequence
motifs with respect to CAL but not BUN virus sequences is
noted for K149, Q163 and P299 in GN, P347 and N455/F456 in
NSm, and H591QH, G601EKCNSA607, E958, K1036, G1243 and
K1411/K1412 in GC.
Pairwise, sliding-window distance analysis (SimPlot; http://
sray.med.som.jhmi.edu/RaySoft/SimPlot/; Lole et al., 1999)
between GROV and BUN and CAL viruses indicated an
almost equidistant position of GROV, with lowest distance
scores in the GN region (approx. position 1–300; Fig. 2a)
and highest scores obtained in the NSm sequence (approx.
position 300–500) and in the N-terminal portion of GC
(approx. position 500–1400). Serogroup-specific differences
appear to be most pronounced in three regions (approx.
positions 100–200, 550–650 and 1200–1275), where a sepa-
ration between sequences of BUNV, CVV and GERV and
CEV, Melao virus (MELV) and Trivittatus virus (TVTV) is
observed. GROV appears to be less distant from BUNV/
GERV/CVV than from CEV/MELV/TVTV in all regions
except for the second part of the second region (at the
N-terminus of GC toward N616), where CEV/MELV/TVTV
are less distant from GROV than BUNV/GERV; however,
CVV remains the most closely related sequence throughout.
In a reconstructed phylogenetic tree, the GROVM-segment
sequence is placed in a closer relationship to sequences of
BUN than of CAL viruses (62% bootstrap support; Fig. 2b).
Phylogenetic relationships of each individual ORF are
similar to that of the entire sequence (data not shown).
A genetic distance of GROV from both serogroups is com-
patible with biological features. Genetic interference has
been observed between CAL viruses in experiments that
mimic interrupted feeding behaviour of mosquitoes (Beaty
et al., 1985; Sundin & Beaty, 1988). Interference was not
observed between CAL viruses and GROV (Beaty et al.,
1983). Cell-culture experiments, however, indicated genetic
distance not only from CAL, but also from BUN, viruses.
Whilst genome-segment reassortment between GROV
mutants was observed, heterologous reassortment was not
observed between GROV and La Crosse virus (LACV),
snowshoe hare virus (SSHV), TVTV or Tahyna virus
(TAHV) (Gentsch et al., 1980), but also not between GROV
and BUNV,Maguari virus or Batai virus (Iroegbu & Pringle,
1981).
The structural determinants of GROV’s unique serological
reaction pattern are obscure. GN is not a major target of
neutralizing antibodies that interfere with infection of
mammalian cells (Ludwig et al., 1989; Cheng et al., 2000)
and the few amino acids that are conserved in GN between
GROV and CAL viruses do not correlate with identified
epitopes of GN (/; Fig. 1; Cheng et al., 2000). Therefore, GN
is unlikely to form major determinants of the reaction of
GROV in NT/HI assays. Likewise, NSm is unlikely to be
involved. Epitopes detected in NT/HI assays have been
mapped to the N-terminal portion of GC, mainly in relation
to the trypsin site of LACV/SSHV (Gonza´lez-Scarano et al.,
1982; Kingsford et al., 1983; Najjar et al., 1985; Kingsford &
Boucquey, 1990). However, their relation to primary amino
acid sequence is not defined and only in one case has a
particular amino acid that is involved in neutralization
been identified (residue 29 of LACV GC; #, Fig. 1; Bupp &
Gonza´lez-Scarano, 1998). The divergence of this region in
comparison to available BUN virus sequences may explain
the lack of cross-reaction between GROV and these viruses
in NT/HI assays. Although also divergent when compared to
sequences of CAL viruses, this region does contain motifs
that are conserved with respect to CAL, but not BUN,
viruses (H591QH and G601EKCNSA607) and two glycosyla-
tion sites. N492, which is conserved amongst CAL but not
BUN virus sequences, is present, whereas N616, which is
conserved amongst BUN but not CAL virus sequences, is
only present in a minority of GROV clones. N492 flanks the
first putative antigenic domain that was proposed by
Brockus & Grimstad (2001) and both conserved amino acid
motifs and N616 are located in their second putative anti-
genic domain. It is conceivable that these positions contri-
bute to the serological reaction of GROV. The mutation at
http://vir.sgmjournals.org 3073
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Fig. 1. Alignment of M-segment sequences of selected CAL [Jamestown Canyon virus (JCV), MELV, Keystone virus (KEYV),
Lumbo virus (LUMV), LACV, CEV and TVTV] and BUN (GERV, CVV and BUNV) viruses with that of GROV. ___, Potential
transmembrane regions; h, potential h-region of predicted signal sequence; |, potential proteolytic cleavage; *, conserved
cysteine; ///, epitopes identified by Cheng et al. (2000); +++, potential glycosylation site; v, conservation between GROV
and CAL serogroup virus sequences; xxx, conserved cleavage motif at C-terminus of GN; bold letters indicate predicted
N-terminus of GC; ttt, potential trypsin cleavage site; #, amino acid position involved in neutralizing epitope of LACV (Bupp &
Gonza´lez-Scarano, 1998). Amino acid positions for the GROV sequence are indicated at the end of each line.
Fig. 2. Phylogenetic analysis of the GROV
M-segment sequence. (a) Sliding-window
distance analysis between GROV, BUN
viruses BUNV, GERV and CVV and CAL
viruses CEV, MELV and TVTV (amino acid
sequence; window, 60 aa, step, 10 aa).
(b) Reconstructed phylogenetic maximum-
likelihood tree for nucleotide sequence. The
tree was constructed by using the ‘subtree
prune regraft’ (SPR) heuristic-search strategy
under the general time-reversible model of
nucleotide substitution with site-specific rate
heterogeneity, modelled by using the
discrete gamma distribution (Yang, 1994).
Parameters were initially estimated on a
neighbour-joining tree. Bootstrap support
resulting from 500 SPR heuristic-search
replicates is indicated for relevant branches.
Oropouche virus (Simbu serogroup) served
as an outgroup to root the tree. GenBank
accession numbers are shown in parenth-
eses. Abbreviations: INKV, Inkoo virus; JSV,
Jerry Slough virus; SAV, San Angelo virus;
SDNV, Serra do Navio virus; SORV, South
River virus.
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the glycosylation site N616DI/T is intriguing, given that
M-segment sequence has been associated with plaque size
(Iroegbu & Pringle, 1981) and the observation that GROV
can generate both large and small plaque morphologies, of
which only the small variant elicited antibodies that were
cross-reactive with CEV and TAHV (Tauraso, 1969).
In summary, our analysis of the GROVM-segment sequence
indicates a relative phylogenetic relationship that is
comparable to that reported for the GROV S-segment
sequence (Fig. 2b; Dunn et al., 1994), and does not provide
evidence for genome-segment reassortment. Instead, in a
sequence that is almost equidistant to published CAL and
BUN virus sequences, isolated determinants in the N-
terminal portion of GC were identified that potentially relate
to the unique serological reaction pattern of GROV and are
more compatible with GROV forming a bridge between
both serogroups, as originally proposed by Whitman &
Shope (1962).
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